Document is current
Any future updates will be listed below
-
Authors
Zorbas, Christiane https://orcid.org/0000-0002-1861-3644
Soenmez, Aynur https://orcid.org/0009-0009-9377-3136
Léger, Jean https://orcid.org/0000-0002-0098-2548
De Vleeschouwer, Christophe https://orcid.org/0000-0001-5049-2929
Lafontaine, Denis LJ https://orcid.org/0000-0001-7295-6288
-
Funding
Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS
Biowin (Holocancer)
EOS (CD-INFLADIS)
European Joint Programme on Rare Diseases (RiboEurope)
European Joint Programme on Rare Diseases (DBAGeneCure)
Région Wallonne (Win4SpinOff [RIBOGENESIS])
COST Action (Epitran (CA16120))
COST Action (Translacore (CA21154))
- License Information
-
More Information
Article History
Received: 15 March 2023
Revised: 4 March 2024
Accepted: 20 March 2024
First Online: 23 April 2024
Disclosure and competing interests statement
: The authors declare that they have no conflict of interest of financial, professional, political, societal, or personal nature with any institute, organization, commercial entity, or person in relation to this work. Although DLJL contributed to the design and solicited the construction of the DHM adapter used in this work, he purchased the finished device from Ovizio s.a. and has no commercial relationship of any sort with Ovizio s.a.
